AIMLogo.jpg
AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update
16 mai 2024 07h30 HE | AIM ImmunoTech Inc.
Continued execution across Ampligen® clinical development programs and growing body of positive data in multiple high-value indications Company to host conference call and webcast today, May...
Saladax Biomedical, Inc. 5-FU Fact Sheet
Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy Therapeutic Drug Monitoring (TDM) Test
14 mai 2024 10h00 HE | Saladax Biomedical, Inc.
Bethlehem, PA, May 14, 2024 (GLOBE NEWSWIRE) -- Saladax Biomedical, Inc. (Saladax) is pleased to announce that Health Canada has approved Saladax’s 5-Fluorouracil (My5-FU) Assay for sale in Canada...
LOGO-01.png
Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
14 mai 2024 02h02 HE | Burning Rock Biotech Limited
Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
Turnstone Logo.jpg
Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
13 mai 2024 17h01 HE | Turnstone Biologics Corp.
Turnstone Biologics Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
Cardiff.jpg
Cardiff Oncology to Present at Upcoming Investor Conferences in May
13 mai 2024 16h05 HE | Cardiff Oncology, Inc.
SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of...
A Pint for Kim 2024
A Pint for Kim Blood Drive Breaks State Record Fifth Year in a Row with More than 700 Donors Showing Up to Give Blood
13 mai 2024 14h43 HE | A Pint for Kim
NAPERVILLE, Ill., May 13, 2024 (GLOBE NEWSWIRE) -- A Pint For Kim, a national grassroots movement created in 2020 in honor of mom Kimberly Sandford who lost her eight-year battle with a rare cancer,...
RNAZ White background cropped.jpg
TransCode Therapeutics Open Letter to Shareholders
13 mai 2024 08h30 HE | TransCode Therapeutics, Inc.
An Open Letter to Shareholders regarding a Reverse Stock Split
Hummingbird.Primary.ColorRGB.png
Hummingbird Bioscience Presents New Preclinical Data Highlighting Next-Generation Antibody-Drug Conjugate Capabilities at PEGS Boston 2024
13 mai 2024 05h30 HE | Hummingbird Bioscience
Hummingbird Bioscience will present next-generation antibody-drug conjugate capabilities at PEGS Boston 2024 for the first time.
KFSH&RC Pushes Boundaries with a Year of Achievements Across Three Centres of Excellence
KFSH&RC Pushes Boundaries with a Year of Achievements Across Three Centres of Excellence KFSH&RC Pushes Boundaries with a Year of Achievements Across Three Centres of Excellence
Vor-Wordmark-RGB-FullColor-070920.png
Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update
09 mai 2024 16h05 HE | Vor Biopharma
On-track for trem-cel and VCAR33ALLO clinical updates in the second half of 2024Trem-cel trial expanded to include patients with myelodysplastic syndromes (MDS); Mylotarg™ dosing has advanced to the...